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rary	outcomes	studies	 is	therefore	 limited.	This	 inadequacy	may	result	 in	a	 lack	of	




erate	 high‐quality,	 contemporary,	 statistically	 robust,	 and	 generalizable	 outcomes	
research	which	 can	 help	 address	 important	 clinical	 questions	 in	 the	 treatment	 of	
CHD.	To	date,	 the	CCRC	has	 reported	on	multicenter	outcomes	 in:	neonates	with	
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1  | INTRODUC TION
A	high	degree	of	variability	attends	nearly	all	 forms	of	therapy	for	













tions.	The	difficulty	 is	particularly	notable	 in	 the	 field	of	pediatric	
cardiology,	where	small	populations	with	anatomically	heterogenous	
cardiac	 malformations	 seemingly	 preclude	 comprehensive	 review	
and	statistical	comparison.	For	example,	despite	the	fact	that	patent	
ductus	 arteriosus	 (PDA)	 stenting	has	been	performed	 in	neonates	
with	 cyanotic	 CHD	 since	 1991,	 the	 largest	 single‐center	 outcome	
studies	 evaluating	 the	 safety	 and	 efficacy	 of	 this	 procedure	 have	
been	limited	to	small	cohorts	of	8‐64	patients,	with	larger	cohorts	
spanning	broad	eras	(Figure	1).1-8	Over	the	inclusion	periods	in	those	
studies,	 concomitant	 advances	 in	 catheter	 and	 stent	 technology	




Given	 the	 relatively	 low	 incidence	of	particular	 forms	of	CHD,	
and	institutional	and	regional	practice	patterns,	we	sought	to	use	a	
multicenter	approach	to	CHD	research	to	mitigate	these	hindrances.	
We	 created	 a	multicenter	 research	 collaborative,	 now	 termed	 the	
Congenital	Catheterization	Research	Collaborative	(CCRC),	in	2013.	
Originally	 consisting	 of	 two	 centers,	 the	 CCRC	 is	 now	 comprised	
of	nine	pediatric	cardiac	centers	from	across	the	United	States.	By	
design,	 the	 CCRC	 includes	 both	 medium‐	 and	 high‐volume	 geo-
graphically	diverse	cardiac	centers.	Despite	differences	in	treatment	
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the	 collaborating	 investigators	 found	 they	 could	 reliably	work	 to-
gether,	 across	 geographic	 and	 technological	 barriers.	 Web‐based	
video	 conference	 calls	 were	 held	 where	 echocardiograms	 and	
catheterization	 angiograms	were	 jointly	 reviewed	and	 interpreted.	
These	video	conferences	facilitated,	for	example,	consistent	meas-




patient	 care	with	 congenital	 aortic	 stenosis,	 including	methods	 of	
valve	 annulus	measurement	 and	 technical	 performance	of	balloon	
aortic	valvuloplasty.
In	 2015,	 the	 CCRC	 grew	 to	 include	 investigators	 from	 the	
Children's	 Hospital	 of	 Philadelphia	 and	 Texas	 Children's	 Hospital.	
The	 resultant	 larger	CCRC	group,	which	would	 go	on	 to	 form	 the	
executive	committee,	sought	to	understand	factors	associated	with	
poor	outcomes	 in	children	with	pulmonary	atresia	and	 intact	ven-





statistical	 power	was	wanting	 (Figure	 1).10-16	 The	CCRC	 studied	 a	
contemporary,	relatively	large	cohort	of	neonates	with	PA‐IVS.	We	
evaluated	 a	 host	 of	 echocardiographic	 and	 hemodynamic	 factors	
and	 identified	 that	 preintervention	 tricuspid	 regurgitation	was	 as-
sociated	with	a	host	of	important	clinical	end	points	following	right	
ventricle	decompression	in	neonates	with	PA‐IVS.17	Additional	anal-




The	 study	 which	 the	 CCRC	 pursued	 next	 was	 a	 comparison	
of	 outcomes	 following	 transcatheter	 PDA	 stenting	 versus	 surgi-
cal	 systemic‐to‐pulmonary	artery	shunts	 (ie,	BT	shunts)	 in	 infants	
with	ductal‐dependent	pulmonary	blood	 flow.	Prior	 to	 this	 study,	
published	reports	were	limited	to	small	case	series	of	PDA	stenting	
procedures	or	rarely,	even	smaller	cohorts	where	outcomes	follow-
ing	PDA	stenting	were	 compared	 to	 those	 following	BT	 shunt.	 In	
both	 types	 of	 studies,	 generalization	 of	 results	was	 restricted	 by	
small	 cohort	 size,	 poor	 statistical	 power,	 and	 institutional	 prefer-








herent	 differences	 in	 cardiac	 anatomy,	 expected	 physiology,	 and	
other	 patient‐	 and	 center‐specific	 factors.19	 Ensuing	 studies	 from	
this	 cohort	 were	 performed	 which	 again	 highlighted	 important	





joined	 the	 CCRC	 including	 members	 from	 Vanderbilt	 University,	










Whenever	 possible,	 the	 CCRC	 draws	 from	 expertise	 beyond	
the	membership	 of	 the	CCRC.	Cardiology	 subspecialists	 in	 nonin-
vasive	imaging,	in	particular,	are	important	collaborators	and	indeed	




places	 a	 high	priority	 on	mentoring	of	 junior	 faculty	 and	 trainees,	





While	 developing	 our	 bylaws	 and	 guidelines,	 the	 CCRC	 executive	
committee	 conferred	 with	 representatives	 from	 established	 and	














Several	 attributes	 separate	 the	 CCRC	 from	 other	 seemingly	
similar	groups.	One	important	distinction	is	that	the	CCRC	is	not	a	




tive	observational	 research,	 the	 focus	of	which	 is	 often,	 although	








B—highly	 granular	 and	 accurate	 data	 collection	 re-
flecting	a	comprehensive	data	auditing	process.
C—pooling	 of	 contemporary	 data	 across	 multiple	























TA B L E  1  Members	of	the	congenital	catheterization	research	collaborative
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years	to	come,	as	more	 junior	members	begin	to	 lead	CCRC’s	aca-
demic	and	organizational	efforts.
4  | CCRC ORGANIZ ATIONAL STRUC TURE 
AND FINANCES























costs	 associated	with	 biannual	 in‐person	meetings	 are	 largely	 un-
derwritten	by	the	CCRC.	Currently,	the	CCRC	enjoys	important	phil-
anthropic	support	from	generous	donors	who	support	the	mission	








DCC.	 These	 2‐3‐day	 in‐person	meetings	 are	 critical	 for	 both	 aca-











are	 shared,	and	a	durable	collegial	 relationship	among	members	 is	
both	established	and	maintained.	Importantly,	the	professional	and	




5  | CCRC DATA QUALIT Y AND AUDITING
The	data	auditing	process	has	matured	over	the	initial	years	of	the	
CCRC’s	existence.	With	 larger	cohort	studies	 involving	an	 increas-
ingly	broad	span	of	data	points,	 it	became	necessary	 to	 introduce	
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a	 thorough	auditing	process.	The	executive	 committee,	 again,	dis-





Program	Manager	 and	Biostatistics	Chair	 develop	 a	 study‐specific	









lead	 investigator	 with	 assistance	 from	 the	 Scientific	 Committee	
chair	will	conduct	audits	of	data	on	regular	intervals.	Random	cases	
(10%‐20%	of	total	cohort	per	site),	assigned	by	the	Biostatistics	Chair,	
will	 be	 reviewed	by:	 (1)	 notification	 of	 the	 site	 principal	 investiga-
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Whenever	 possible,	 data	 extraction	 for	 specific	 studies	 will	
be	 enhanced	 by	 utilizing	 site‐specific	 data	 warehouses—eg,	
Lumedx	 (Cardiovascular	 Data	 Intelligence,	 Oakland,	 California)	 or	
CardioAccess	 (CardioAccess	 Inc,	 Fort	 Lauderdale,	 Florida)—which	
offer	the	benefit	of	prior	review	and	confirmation	of	all	datapoints	
by	 each	 site's	 internal	 bioinformatics	 team.	 Use	 of	 institutional	
data	 warehouses	 is	 achieved	 using	 common	 diagnostic	 or	 proce-
dural	codes	derived	from	either	the	 Improving	Pediatric	and	Adult	
Congenital	Treatment	(IMPACT)	registry	or	the	Society	of	Thoracic	
Surgeons	 (STS)	 Congenital	 database.26,29	 Use	 of	 these	 common	
codes	across	the	registries	(and	therefore	across	CCRC	centers,	all	
of	 which	 participate	 in	 these	 registries)	 ensures	 standardization,	
appropriate	 patient	 inclusion,	 and	 common	 procedure	 definitions.	




6  | CCRC FUTURE DIREC TIONS
To	 date,	 the	 CCRC	 has	 undertaken	 strictly	 retrospective,	 compre-












uation	 of	 neurodevelopmental	 outcomes	 following	 catheter‐based	
palliation	 for	 infants	with	 CHD,	 comparative	 studies	 based	 on	 in-
tention‐to‐treat	 analysis	 (which	 is	 unachievable	 in	 a	 retrospective	





















facilitate	discrete	quality	 improvement	 efforts	 related	 to	 interven-
tional	 procedures	 and	 their	 outcomes.	We	 also	 plan	 to	 study	 pa-




on	 improving	 outcomes,	 establishing	 procedural	 benchmarks,	 and	
performing	comparative	research.	We	believe	that	hypothesis‐driven	











help	 improve	 our	 understanding	 of	 the	 outcomes	 following	 CHD	
interventions.
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